When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

Published Date: 15 Dec 2023

Improvements in 2-year PFS and OS, but not for primary refractory illness.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer

2.

AI innovation unlocks non-surgical way to detect brain cancer spread

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

5.

Kate Middleton Reaches Cancer Treatment Milestone


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot